Abstract
Pediatric encephalitis has significant morbidity and mortality, yet 50% of cases are unexplained. Host genetics plays a role in encephalitis’ development; however, the contributing variants are poorly understood. One child with anti-NMDA receptor encephalitis and ten with unexplained encephalitis underwent whole genome sequencing to identify rare candidate variants in genes known to cause monogenic immunologic and neurologic disorders, and polymorphisms associated with increased disease risk. Using the professional Human Genetic Mutation Database (Qiagen), we divided the candidate variants into three categories: monogenic deleterious or potentially deleterious variants (1) in a disease-consistent inheritance pattern; (2) in carrier states; and (3) disease-related polymorphisms. Six patients (55%) had a deleterious or potentially deleterious variant in a disease-consistent inheritance pattern, five (45%) were heterozygous carriers for an autosomal recessive condition, and six (55%) carried a disease-related polymorphism. Finally, seven (64%) had more than one variant, suggesting possible polygenetic risk. Among variants identified were those implicated in atypical hemolytic uremic syndrome, common variable immunodeficiency, hemophagocytic lymphohistiocytosis, and systemic lupus erythematosus. This preliminary study shows genetic variation related to inborn errors of immunity in acute pediatric encephalitis. Future research is needed to determine if these variants play a functional role in the development of unexplained encephalitis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The authors confirm that the data supporting the finding of this study are available within the article and its Supplementary Material. Raw data supporting the findings are available from the corresponding author upon reasonable request.
References
Messacar K, Fischer M, Dominguez SR, Tyler KL, Abzug MJ. Encephalitis in US children. Infect Dis Clin North Am. 2018;32:145–62.
Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998–2000. Clin Infect Dis. 2003;36:731–42.
Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–28.
Blincoe A, Heeg M, Campbell PK, Hines M, Khojah A, Klein-Gitelman M, et al. Neuroinflammatory disease as an isolated manifestation of hemophagocytic lymphohistiocytosis. J Clin Immunol. 2020;40:901–16.
Ramirez GA, Lanzani C, Bozzolo EP, Citterio L, Zagato L, Casamassima N, et al. TRPC6 gene variants and neuropsychiatric lupus. J Neuroimmunol. 2015;288:21–4.
Guo Y, Audry M, Ciancanelli M, Alsina L, Azevedo J, Herman M, et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med. 2011;208:2083–98.
Fabric Genomics. Fabric Genomics Opal Genome Interpretation Platform®. 2022. https://fabricgenomics.com/.
Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24–64.
McCreary D, Omoyinmi E, Hong Y, Mulhern C, Papadopoulou C, Casimir M, et al. Development and validation of a targeted next-generation sequencing gene panel for children with neuroinflammation. JAMA Netw Open. 2019;2:1914274.
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.
Stenson PD, Ball EV, Mort M, Phillips AD, Shaw K, Cooper DN. The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution. Curr Protoc Bioinformatics. 2012. https://doi.org/10.1002/0471250953.bi0113s39.
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University. Online Mendelian Inheritance in Man, OMIM®. https://omim.org/.
Goldberg BS, Ackerman ME. Antibody-mediated complement activation in pathology and protection. Immunol Cell Biol. 2020;98:305–17.
Sanders ME, Alexander EL, Koski CL, Frank MM, Joiner KA. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren’s syndrome or systemic lupus erythematosus. J Immunol. 1987;138:2095–9.
Jacob A, Hack B, Chiang E, Garcia JGN, Quigg RJ, Alexander JJ. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 2010;24:1682–8.
Chua GT, Zhou D, Ho ACC, Chan SHS, Yu CY, Lau YL. A case report of complement C4B deficiency in a patient with steroid and IVIG-refractory anti-NMDA receptor encephalitis. BMC Neurol. 2020. https://doi.org/10.1186/s12883-020-01906-x.
Shu Y, Chen C, Chen Y, Xu Y, Chang Y, Li R, et al. Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis. Eur J Neurol. 2018;25:178–84.
Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology. 2011;77:589–93.
Fidan K, Göknar N, Gülhan B, Melek E, Yıldırım ZY, Baskın E, et al. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2018;33:1395–403.
Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol. 2019;34:1337–48.
Shields AM, Pagnamenta AT, Pollard AJ, Taylor JC, Allroggen H, Patel SY. Classical and non-classical presentations of complement factor I deficiency: two contrasting cases diagnosed via genetic and genomic methods. Front Immunol. 2019;10:1150.
Altmann T, Torvell M, Owens S, Mitra D, Sheerin NS, Morgan BP, et al. Complement factor I deficiency: a potentially treatable cause of fulminant cerebral inflammation. Neurol Neuroimmunol Neuroinflamm. 2020;7:e689.
Dai D, Wen F, Liu S, Zhou S. Brain damage resembling acute necrotizing encephalopathy as a specific manifestation of haemophagocytic lymphohistiocytosis-induced by hypersensitivity. Ital J Pediatr. 2016;42:79.
Cagdas D, Mayr D, Baris S, Worley L, Langley DB, Metin A, et al. Genomic spectrum and phenotypic heterogeneity of human IL-21 receptor deficiency. J Clin Immunol. 2021;41:1272–90.
Kotlarz D, Ziȩtara N, Uzel G, Weidemann T, Braun CJ, Diestelhorst J, et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med. 2013;210:433–43.
Acknowledgements
Funding was provided in part by NIH K12HD047349 (Kernan), University of Pittsburgh Medical Center Institute of Precision Medicine (Kernan), Children's Neuroscience Institute (Kernan), Brackenridge Fellowship University of Pittsburgh (Malik). DSR was supported by the Children's Neuroscience Institute (Rajan) and Scleroderma Foundation (Rajan).
Author information
Authors and Affiliations
Contributions
All authors contributed to the article and approved the submitted version. KFK and DM designed study, generated and analyzed the data, conceptualized, wrote and edited the manuscript. DWS, DSR, and KT analyzed the data and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The study was approved by the Institutional Review Board at the University of Pittsburgh (#20010099). Written informed consent was obtained from one or more parents/guardians for each child. Written assent was garnered when the child was able. Written informed consent was obtained for participation in the study, as well as consent for publication of study results.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Malik, D., Simon, D.W., Thakkar, K. et al. Genetic variation in genes of inborn errors of immunity in children with unexplained encephalitis. Genes Immun 23, 235–239 (2022). https://doi.org/10.1038/s41435-022-00185-5
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41435-022-00185-5


